Modular Medical, Inc. (MODD) — Financial statements
Income statement, balance sheet, and cash flow for Modular Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 1↑86.6% | 0.77↑116.1% | 0.36↑80.5% | 0.20 | |
| Gross Profit | 0.00↑100.0% | -1↓86.6% | -0.77↓116.1% | -0.36↓80.5% | -0.20 | |
| Operating Expenses | ||||||
| R&D Expenses | 20↑35.9% | 15↑14.1% | 13↑42.1% | 9↑17.2% | 8 | |
| General & Administrative Expenses | 8 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 8↑160.0% | 3↓24.8% | 4↓13.0% | 4↓36.3% | 7 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 28↑56.5% | 18↑5.1% | 17↑23.9% | 14↓8.2% | 15 | |
| Total Costs & Expenses | 0.00↓100.0% | 19↑8.7% | 18↑26.3% | 14↓7.0% | 15 | |
| Operating Results | ||||||
| Operating Income | -28↓44.7% | -19↓8.7% | -18↓26.3% | -14↑7.0% | -15 | |
| Depreciation & Amortization | 0.00↓100.0% | 1↑86.6% | 0.77↑116.1% | 0.36↑80.5% | 0.20 | |
| EBITDA | -28↓58.5% | -17↓4.1% | -17↓23.5% | -14↑13.8% | -16 | |
| EBIT | 0.00↑100.0% | -19↓7.8% | -17↓25.9% | -14↑12.6% | -16 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -3 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 3 | |
| Non-Operating Income | 0.00↑100.0% | -0.23↓270.5% | -0.06↓6124.5% | -0.00↓100.1% | 0.95 | |
| Other Income / Expenses | -0.68↓400.9% | 0.23↑270.5% | 0.06↑6156.4% | 0.00↑100.0% | -4 | |
| Income Before Tax | -28↓50.0% | -19↓7.8% | -17↓25.9% | -14↑25.5% | -19 | |
| Income Tax Expense | 0.00↑0.0% | 0.00↑0.0% | 0.00↑25.0% | 0.00↑0.0% | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -28↓50.0% | -19↓7.8% | -17↓25.9% | -14↑25.5% | -19 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -28↓50.0% | -19↓7.8% | -17↓25.9% | -14↑25.5% | -19 | |
| Bottom-Line Net Income | -28↓50.0% | -19↓7.8% | -17↓25.9% | -14↑25.5% | -19 | |
| EPS (Basic) | -12.36↑19.2% | -15.30↑34.6% | -23.40↑39.1% | -38.40↑53.3% | -82.20 | |
| EPS (Diluted) | -12.36↑19.2% | -15.30↑34.6% | -23.40↑39.1% | -38.40↑53.3% | -82.20 | |
| Weighted Average Shares | 2↑85.2% | 1↑65.4% | 0.75↑105.7% | 0.36↑59.8% | 0.23 | |
| Weighted Average Diluted Shares | 2↑85.2% | 1↑65.4% | 0.75↑105.7% | 0.36↑59.8% | 0.23 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.